REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Condition(s):Cervical Dysplasia; Cervical High Grade Squamous Intraepithelial Lesion; HSILLast Updated:July 27, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Cervical Dysplasia; Cervical High Grade Squamous Intraepithelial Lesion; HSILLast Updated:July 27, 2023Completed
Condition(s):Cervical Carcinoma; Cervical Intraepithelial Neoplasia Grade 2/3; Stage 0 Cervical CancerLast Updated:September 15, 2017Completed
Condition(s):Human Papillomavirus Infection; Self Sampling; Vaginal DischargeLast Updated:April 22, 2022Completed
Condition(s):Opioid Induced Respiratory DepressionLast Updated:May 23, 2013Completed
Condition(s):Cervical Intraepithelial Neoplasia Grade 2/3Last Updated:April 28, 2021Unknown status
Condition(s):Human Papilloma Virus; Dysplasia; CIN1; CIN2Last Updated:January 20, 2021Completed
Condition(s):Cervical Cancer; Precancerous ConditionLast Updated:August 1, 2017Withdrawn
Condition(s):Cervical Intraepithelial Neoplasia; Cervical DysplasiaLast Updated:September 7, 2023Completed
Condition(s):Cervical Cancer; Precancerous ConditionLast Updated:July 20, 2018Completed
Condition(s):Cervical DiseaseLast Updated:August 15, 2014Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.